• Picard Medical will execute a 1-for-50 reverse stock split to support compliance with NYSE American listing standards.
• Split takes effect at 5 p.m. ET on July 31, 2026; shares begin trading on a split-adjusted basis on Aug. 3 under PMI.
• Every 50 common shares will convert into 1 share; fractional shares will be rounded up to the nearest whole share.
• Outstanding equity awards, warrants, other convertible securities will be adjusted proportionately under their terms.
• Stock will receive a new CUSIP: 71953R 207.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607212048PRIMZONEFULLFEED9766066) on July 22, 2026, and is solely responsible for the information contained therein.